Brain Functional and Structural Changes in Alzheimer's Disease With Sleep Disorders: A Systematic Review

Abstract

Introduction: Sleep disorders (SLD) are supposed to be associated with increased risk and development of Alzheimer's disease (AD), and patients with AD are more likely to show SLD. However, neurobiological performance of patients with both AD and SLD in previous studies is inconsistent, and identifying specific patterns of the brain functional network and structural characteristics in this kind of comorbidity is warranted for understanding how AD and SLD symptoms interact with each other as well as finding effective clinical intervention. Thus, the aims of this systematic review were to summarize the relevant findings and their limitations and provide future research directions.Methods: A systematic search on brain functional and structural changes in patients with both AD and SLD was conducted from PubMed, Web of Science, and EMBASE databases.Results: Nine original articles published between 2009 and 2021 were included with a total of 328 patients with comorbid AD and SLD, 367 patients with only AD, and 294 healthy controls. One single-photon emission computed tomography study and one multislice spiral computed tomography perfusion imaging study investigated changes of cerebral blood flow; four structural magnetic resonance imaging (MRI) studies investigated brain structural changes, two of them used whole brain analysis, and another two used regions of interest; two resting-state functional MRI studies investigated brain functional changes, and one 2-deoxy-2-(18F)fluoro-d-glucose positron emission tomography (18F-FDG-PET) investigated 18F-FDG-PET uptake in patients with comorbid AD and SLD. Findings were inconsistent, ranging from default mode network to sensorimotor cortex, hippocampus, brain stem, and pineal gland, which may be due to different imaging techniques, measurements of sleep disorder and subtypes of AD and SLD.Conclusions: Our review provides a systematic summary and promising implication of specific neuroimaging dysfunction underlying co-occurrence of AD and SLD. However, limited and inconsistent findings still restrict its neurobiological explanation. Further studies should use unified standards and comprehensive brain indices to investigate the pathophysiological basis of interaction between AD and SLD symptoms in the development of the disease spectrums.

Neuro-Navigated rTMS Improves Sleep and Cognitive Impairment via Regulating Sleep-Related Networks’ Spontaneous Activity in AD Spectrum Patients

“…Because auditory sensation still retains a certain degree of sensitivity, especially with emotionally relevant inputs during sleep, 45 patients' anxiety and fear of poor sleep further strengthened their sleep awakening, 48 and the lowering of the threshold of arousal disturbed the continuity and sensitivity of brain activities during sleep, such as sensory-motor and sound perception processing, which caused the spontaneous activity of the affective auditory processing and sensorymotor collaborative network to decrease, which was also consistent with previous research results on insomnia. 49,50 However, the group effects of the sleep-related network obtained by us were all located in the left hemisphere, which may be related to previous studies' conclusion that the left hemisphere plays a dominant role in speech processing 51 and is involved in tasks that require conscious emotional processing. 52 rTMS was considered to be effective in improving sleep and cognition through different stimulation targets and different intensities.…”

An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease

“…Decision-making dysfunction in the early phases could be mild to severe. Linguistic malfunction and visual-spatial performance degradation come next [42]. During the middle to late stages, it is common to experience nervous system-associated psychiatric indications such as lethargy, wandering, social disengagement, psychosis, and anxiety.…”

Positron Emission Tomography Molecular Imaging of the Major Neurodegenerative Disorders: Overview and Pictorial Essay, from a Nuclear Medicine Center's Perspective

“…Hypometabolism in the frontal lobes may also be found in advanced AD patients. In NDs, sparing of the sensorimotor cortex may also be observed in an ad-vanced stage of the disease [30]. To improve diagnostic accuracy, some studies support the utility of the dual tracer brain PET with both [ 18 F]FDG and amyloid tracers in the diagnostic workup of AD (Fig.…”